Skip to content
10-Q

Quarterly Report

VYCOR MEDICAL, INC. VYCO

0001493152-24-031547

← back to feed
Filed
Aug 13, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Aug 13, 2024 32.63M sh
Cash And Equivalents Q2 2024 · Jun 30, 2024 $119.3K
Cash And Equivalents Q2 2024 · Dec 31, 2023 $57.29K
Current Liabilities Q2 2024 · Jun 30, 2024 $4.31M
Current Liabilities Q2 2024 · Dec 31, 2023 $4.07M
Total Liabilities Q2 2024 · Jun 30, 2024 $4.53M
Total Liabilities Q2 2024 · Dec 31, 2023 $4.32M
Current Assets Q2 2024 · Jun 30, 2024 $643.49K
Current Assets Q2 2024 · Dec 31, 2023 $584.09K
Total Assets Q2 2024 · Jun 30, 2024 $996.97K
Total Assets Q2 2024 · Dec 31, 2023 $992.3K
Shares Diluted Q2 2024 · Jun 30, 2023 37.47M sh
Shares Diluted Q2 2024 · Jun 30, 2023 37.42M sh
Operating Cash Flow restated Q2 2024 · Jun 30, 2023 $38.79K
Stockholders Equity Q2 2024 · Jun 30, 2023 −$3.02M
Stockholders Equity Q2 2024 · Mar 31, 2023 −$3.1M
Stockholders Equity Q2 2024 · Dec 31, 2022 −$2.94M
Eps Diluted Q2 2024 · Jun 30, 2023 $0.00
Eps Diluted Q2 2024 · Jun 30, 2023 $0.00
Eps Basic Q2 2024 · Jun 30, 2023 $0.00
Eps Basic Q2 2024 · Jun 30, 2023 $0.00
Sga Expense Q2 2024 · Jun 30, 2023 $324.53K
Sga Expense Q2 2024 · Jun 30, 2023 $601.63K
Rd Expense Q2 2024 · Jun 30, 2023 $7.55K
Rd Expense Q2 2024 · Jun 30, 2023 $13.06K
Net Income Q2 2024 · Jun 30, 2023 $68.41K
Net Income Q2 2024 · Jun 30, 2023 $75.27K
Operating Income Q2 2024 · Jun 30, 2023 $96.52K
Operating Income Q2 2024 · Jun 30, 2023 $129.73K
Gross Profit Q2 2024 · Jun 30, 2023 $442.97K
Gross Profit Q2 2024 · Jun 30, 2023 $773.17K
Cost Of Revenue Q2 2024 · Jun 30, 2023 $39.8K
Cost Of Revenue Q2 2024 · Jun 30, 2023 $70.6K
Revenue Q2 2024 · Jun 30, 2023 $482.77K
Revenue Q2 2024 · Jun 30, 2023 $843.76K